United Kingdom · 
What does Advent Life Sciences Llp invest in?
Advent Life Sciences Llp invests most often at Series C and Series A (60% of the rounds on record), in sectors such as Life Sciences, Drug Discovery and Med Tech.
Advent Life Sciences Llp highlights
- 01
16 rounds on record
- 02
Mostly Series C and Series A: 60% of its rounds
- 03
Sole investor in 1 rounds, median $3.1M
- 04
1 exits from the portfolio
What they do
Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $25K – $5.0M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- Life SciencesDrug DiscoveryMed Tech
- Based in
- London, United Kingdom
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first16 appearances
- 2022
1 round
- Apr
- 2019
1 round
- Oct
- 2018
2 rounds
- Aug
- Apr
- 2017
4 rounds
- Oct
- May
- Apr
- Mar
- 2015
3 rounds
- Sept
- Sept
- Mar
- 2014
2 rounds
- Oct
- Feb
- 2013
2 rounds
- Dec
- Aug
- 2012
1 round
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration9 named
ALAdvent Life Sciences LLPGeneral PartneriFiling they signed
DPDale PfostExecutive OfficeriFiling they signed
DSDominic SchmidtExecutive Officer, PromoteriFiling they signed
KMKaaism MahmoodExecutive OfficeriFiling they signed
KMKaasim MahmoodGeneral Partner of ManageriFiling they signed
MSMohammed Shahzad Ahmed MalikGeneral PartneriForm ADV
RPRajesh ParekhExecutive OfficeriFiling they signed
SKSaiyed Kaasim MahmoodGeneral PartneriForm ADV
SMShahzad MalikExecutive OfficeriFiling they signed
We also hold 30 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$830Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Advent LIFE Sciences LLP
- SEC number
- CRD 173031
What they claim to have backed
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
CN CreativeBought by British American TobaccoUndisclosedDec 2012
An exit counts when it came after the firm's first round in the company. From historical deal records.